A genome-wide association study was performed using the Affymetrix 6.0 chip to identify
genes associated with diabetic nephropathy in African Americans. Association analysis was …

A genome scan for diabetic nephropathy in African Americans. Background There is
substantial evidence for a genetic contribution to diabetic nephropathy susceptibility in the …

Type 2 diabetes (T2D)-associated end-stage kidney disease (ESKD) is a complex disorder
resulting from the combined influence of genetic and environmental factors. This study …

African Americans are disproportionately affected by type 2 diabetes (T2DM) yet few studies
have examined T2DM using genome-wide association approaches in this ethnicity. The aim …

OBJECTIVE Genetic factors are believed to contribute to the development and progression
of diabetic nephropathy. Recently, a genome-wide association study for diabetic …

African Americans have increased susceptibility to non-diabetic (non-DM) forms of end-
stage renal disease (ESRD) and extensive evidence supports a genetic contribution. A …

Background End-stage kidney disease (ESKD) is a significant public health concern
disproportionately affecting African Americans (AAs). Type 2 diabetes (T2D) is the leading …

OBJECTIVE Despite extensive evidence for genetic susceptibility to diabetic nephropathy,
the identification of susceptibility genes and their variants has had limited success. To …

OBJECTIVE—Diabetic nephropathy, the most common cause of end-stage renal disease,
aggregates in families and specific ethnic groups. Deconstructing diabetic nephropathy into …

Type 2 diabetes is highly prevalent and is the major cause of progressive chronic kidney
disease in American Indians. Genome-wide association studies identified several loci …